欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/0972/001
药品名称Lamivudina + Zidovudina Hetero
活性成分
    • Lamivudine 150.0 mg
    • Zidovudine 300.0 mg
剂型Film-coated tablet
上市许可持有人Hetero Europe S.L.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Sweden (SE)
    • France (FR)
    • Italy (IT)
    • Bulgaria (BG)
    • Denmark (DK)
    • Hungary (HU)
      LAMIVUDINE/ZIDOVUDINE ACCORD 150 mg/300 mg filmtabletta
    • Norway (NO)
    • Malta (MT)
      Lamivudine/Zidovudine 150 mg/300 mg film-coated tablets
    • Czechia (CZ)
      Lamivudine/Zidovudine Accord 150 mg/300 mg potahované tablety
    • Finland (FI)
    • Slovakia (SK)
      Lamivudín/Zidovudín Accord 150 mg/300 mg
许可日期2013/07/25
最近更新日期2024/10/11
药物ATC编码
    • J05AR01 zidovudine and lamivudine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase